Cross-priming for antitumor CTL induced by soluble Ag + polyI:C depends on the TICAM-1 pathway in mouse CD11c⁺/CD8α⁺ dendritic cells

References

• Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010; 327:291 - 5; http://dx.doi.org/10.1126/science.1183021; PMID: 20075244
   PubMed Web of Science ®Google Scholar
• Seya T, Shime H, Ebihara T, Oshiumi H, Matsumoto M. Pattern recognition receptors of innate immunity and their application to tumor immunotherapy. Cancer Sci 2010; 101:313 - 20; http://dx.doi.org/10.1111/j.1349-7006.2009.01442.x; PMID: 20059475
   PubMed Web of Science ®Google Scholar
• Akira S. Toll-like receptor signaling. J Biol Chem 2003; 278:38105 - 8; http://dx.doi.org/10.1074/jbc.R300028200; PMID: 12893815
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 2009; 21:317 - 37; http://dx.doi.org/10.1093/intimm/dxp017; PMID: 19246554
   PubMed Web of Science ®Google Scholar
• Longman RS, Braun D, Pellegrini S, Rice CM, Darnell RB, Albert ML. Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-alpha/beta on antigen cross-presentation. Blood 2007; 109:1113 - 22; http://dx.doi.org/10.1182/blood-2006-05-023465; PMID: 17018853
   PubMed Web of Science ®Google Scholar
• Shinohara ML, Kim JH, Garcia VA, Cantor H. Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. Immunity 2008; 29:68 - 78; http://dx.doi.org/10.1016/j.immuni.2008.05.008; PMID: 18619869
   PubMed Web of Science ®Google Scholar
• Diebold SS. Recognition of viral single-stranded RNA by Toll-like receptors. Adv Drug Deliv Rev 2008; 60:813 - 23; http://dx.doi.org/10.1016/j.addr.2007.11.004; PMID: 18241955
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Oshiumi H, Seya T. Antiviral responses induced by the TLR3 pathway. Rev Med Virol 2011; Epub ahead of print http://dx.doi.org/10.1002/rmv.680; PMID: 21312311
   PubMed Web of Science ®Google Scholar
• Yoneyama M, Fujita T. RIG-I family RNA helicases: cytoplasmic sensor for antiviral innate immunity. Cytokine Growth Factor Rev 2007; 18:545 - 51; http://dx.doi.org/10.1016/j.cytogfr.2007.06.023; PMID: 17683970
   PubMed Web of Science ®Google Scholar
• Seya T, Matsumoto M. The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer. Cancer Immunol Immunother 2009; 58:1175 - 84; http://dx.doi.org/10.1007/s00262-008-0652-9; PMID: 19184005
   PubMed Web of Science ®Google Scholar
• Akazawa T, Ebihara T, Okuno M, Okuda Y, Shingai M, Tsujimura K, et al. Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells. Proc Natl Acad Sci U S A 2007; 104:252 - 7; http://dx.doi.org/10.1073/pnas.0605978104; PMID: 17190817
   PubMed Web of Science ®Google Scholar
• Ebihara T, Azuma M, Oshiumi H, Kasamatsu J, Iwabuchi K, Matsumoto K, et al. Identification of a polyI:C-inducible membrane protein that participates in dendritic cell-mediated natural killer cell activation. J Exp Med 2010; 207:2675 - 87; http://dx.doi.org/10.1084/jem.20091573; PMID: 21059856
   PubMed Web of Science ®Google Scholar
• Perrot I, Deauvieau F, Massacrier C, Hughes N, Garrone P, Durand I, et al. TLR3 and Rig-like receptor on myeloid dendritic cells and Rig-like receptor on human NK cells are both mandatory for production of IFN-gamma in response to double-stranded RNA. J Immunol 2010; 185:2080 - 8; http://dx.doi.org/10.4049/jimmunol.1000532; PMID: 20639488
   PubMed Web of Science ®Google Scholar
• Bevan MJ. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med 1976; 143:1283 - 8; http://dx.doi.org/10.1084/jem.143.5.1283; PMID: 1083422
   PubMed Web of Science ®Google Scholar
• Datta SK, Redecke V, Prilliman KR, Takabayashi K, Corr M, Tallant T, et al. A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells. J Immunol 2003; 170:4102 - 10; PMID: 12682240
   PubMed Web of Science ®Google Scholar
• Schulz O, Diebold SS, Chen M, Näslund TI, Nolte MA, Alexopoulou L, et al. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature 2005; 433:887 - 92; http://dx.doi.org/10.1038/nature03326; PMID: 15711573
   PubMed Web of Science ®Google Scholar
• Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008; 8:279 - 89; http://dx.doi.org/10.1038/nri2215; PMID: 18340345
   PubMed Web of Science ®Google Scholar
• Le Bon A, Etchart N, Rossmann C, Ashton M, Hou S, Gewert D, et al. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat Immunol 2003; 4:1009 - 15; http://dx.doi.org/10.1038/ni978; PMID: 14502286
   PubMed Web of Science ®Google Scholar
• Bennett SR, Carbone FR, Karamalis F, Miller JF, Heath WR. Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med 1997; 186:65 - 70; http://dx.doi.org/10.1084/jem.186.1.65; PMID: 9206998
   PubMed Web of Science ®Google Scholar
• Shimizu K, Kurosawa Y, Taniguchi M, Steinman RM, Fujii S. Cross-presentation of glycolipid from tumor cells loaded with alpha-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells. J Exp Med 2007; 204:2641 - 53; http://dx.doi.org/10.1084/jem.20070458; PMID: 17923500
   PubMed Web of Science ®Google Scholar
• Kumar H, Koyama S, Ishii KJ, Kawai T, Akira S. Cutting edge: cooperation of IPS-1- and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses. J Immunol 2008; 180:683 - 7; PMID: 18178804
   PubMed Web of Science ®Google Scholar
• Jelinek I, Leonard JN, Price GE, Brown KN, Meyer-Manlapat A, Goldsmith PK, et al. TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection. J Immunol 2011; 186:2422 - 9; http://dx.doi.org/10.4049/jimmunol.1002845; PMID: 21242525
   PubMed Web of Science ®Google Scholar
• Wang Y, Cella M, Gilfillan S, Colonna M. Cutting edge: polyinosinic:polycytidylic acid boosts the generation of memory CD8 T cells through melanoma differentiation-associated protein 5 expressed in stromal cells. J Immunol 2010; 184:2751 - 5; http://dx.doi.org/10.4049/jimmunol.0903201; PMID: 20164430
   PubMed Web of Science ®Google Scholar
• Carbone FR, Bevan MJ. Induction of ovalbumin-specific cytotoxic T cells by in vivo peptide immunization. J Exp Med 1989; 169:603 - 12; http://dx.doi.org/10.1084/jem.169.3.603; PMID: 2784478
   PubMed Web of Science ®Google Scholar
• Asano J, Tada H, Onai N, Sato T, Horie Y, Fujimoto Y, et al. Nucleotide oligomerization binding domain-like receptor signaling enhances dendritic cell-mediated cross-priming in vivo. J Immunol 2010; 184:736 - 45; http://dx.doi.org/10.4049/jimmunol.0900726; PMID: 20008287
   PubMed Web of Science ®Google Scholar
• McCartney S, Vermi W, Gilfillan S, Cella M, Murphy TL, Schreiber RD, et al. Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells. J Exp Med 2009; 206:2967 - 76; http://dx.doi.org/10.1084/jem.20091181; PMID: 19995959
   PubMed Web of Science ®Google Scholar
• Watanabe A, Tatematsu M, Saeki K, Shibata S, Shime H, Yoshimura A, et al. Raftlin is involved in the nucleocapture complex to induce poly(I:C)-mediated TLR3 activation. J Biol Chem 2011; 286:10702 - 11; http://dx.doi.org/10.1074/jbc.M110.185793; PMID: 21266579
   PubMed Web of Science ®Google Scholar
• Itoh K, Watanabe A, Funami K, Seya T, Matsumoto M. The clathrin-mediated endocytic pathway participates in dsRNA-induced IFN-beta production. J Immunol 2008; 181:5522 - 9; PMID: 18832709
   PubMed Web of Science ®Google Scholar
• Talmadge JE, Adams J, Phillips H, Collins M, Lenz B, Schneider M, et al. Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose. Cancer Res 1985; 45:1058 - 65; PMID: 3155990
   PubMed Web of Science ®Google Scholar
• Conforti R, Ma Y, Morel Y, Paturel C, Terme M, Viaud S, et al. Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands. Cancer Res 2010; 70:490 - 500; http://dx.doi.org/10.1158/0008-5472.CAN-09-1890; PMID: 20068181
   PubMed Web of Science ®Google Scholar
• Kaiser WJ, Offermann MK. Apoptosis induced by the toll-like receptor adaptor TRIF is dependent on its receptor interacting protein homotypic interaction motif. J Immunol 2005; 174:4942 - 52; PMID: 15814722
   PubMed Web of Science ®Google Scholar
• Zhang Z, Kim T, Bao M, Facchinetti V, Jung SY, Ghaffari AA, et al. DDX1, DDX21, and DHX36 helicases form a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells. Immunity 2011; 34:866 - 78; http://dx.doi.org/10.1016/j.immuni.2011.03.027; PMID: 21703541
   PubMed Web of Science ®Google Scholar
• Gitlin L, Barchet W, Gilfillan S, Cella M, Beutler B, Flavell RA, et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A 2006; 103:8459 - 64; http://dx.doi.org/10.1073/pnas.0603082103; PMID: 16714379
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Seya T. TLR3: interferon induction by double-stranded RNA including poly(I:C). Adv Drug Deliv Rev 2008; 60:805 - 12; http://dx.doi.org/10.1016/j.addr.2007.11.005; PMID: 18262679
   PubMed Web of Science ®Google Scholar
• Absher M, Stinebring WR. Toxic properties of a synthetic double-stranded RNA. Endotoxin-like properties of poly I. poly C, an interferon stimulator. Nature 1969; 223:715 - 7; http://dx.doi.org/10.1038/223715a0; PMID: 5805520
   PubMed Web of Science ®Google Scholar
• Berry LJ, Smythe DS, Colwell LS, Schoengold RJ, Actor P. Comparison of the effects of a synthetic polyribonucleotide with the effects of endotoxin on selected host responses. Infect Immun 1971; 3:444 - 8; PMID: 16557994
   PubMed Web of Science ®Google Scholar
• Sasai M, Shingai M, Funami K, Yoneyama M, Fujita T, Matsumoto M, et al. NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction. J Immunol 2006; 177:8676 - 83; PMID: 17142768
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 2008; 455:674 - 8; http://dx.doi.org/10.1038/nature07317; PMID: 18724357
   PubMed Web of Science ®Google Scholar
• Taniguchi T, Takaoka A. A weak signal for strong responses: interferon-alpha/beta revisited. Nat Rev Mol Cell Biol 2001; 2:378 - 86; http://dx.doi.org/10.1038/35073080; PMID: 11331912
   PubMed Web of Science ®Google Scholar
• Ogasawara S, Yano H, Momosaki S, Akiba J, Nishida N, Kojiro S, et al. Growth inhibitory effects of IFN-beta on human liver cancer cells in vitro and in vivo. J Interferon Cytokine Res 2007; 27:507 - 16; http://dx.doi.org/10.1089/jir.2007.0183; PMID: 17572015
   PubMed Web of Science ®Google Scholar
• Ebihara T, Shingai M, Matsumoto M, Wakita T, Seya T. Hepatitis C virus-infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells. Hepatology 2008; 48:48 - 58; http://dx.doi.org/10.1002/hep.22337; PMID: 18537195
   PubMed Web of Science ®Google Scholar
• Chaput N, Conforti R, Viaud S, Spatz A, Zitvogel L. The Janus face of dendritic cells in cancer. Oncogene 2008; 27:5920 - 31; http://dx.doi.org/10.1038/onc.2008.270; PMID: 18836473
   PubMed Web of Science ®Google Scholar
• Burgdorf S, Schölz C, Kautz A, Tampé R, Kurts C. Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nat Immunol 2008; 9:558 - 66; http://dx.doi.org/10.1038/ni.1601; PMID: 18376402
   PubMed Web of Science ®Google Scholar
• Shen L, Sigal LJ, Boes M, Rock KL. Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity 2004; 21:155 - 65; http://dx.doi.org/10.1016/j.immuni.2004.07.004; PMID: 15308097
   PubMed Web of Science ®Google Scholar
• Kurotaki T, Tamura Y, Ueda G, Oura J, Kutomi G, Hirohashi Y, et al. Efficient cross-presentation by heat shock protein 90-peptide complex-loaded dendritic cells via an endosomal pathway. J Immunol 2007; 179:1803 - 13; PMID: 17641047
   PubMed Web of Science ®Google Scholar
• Gagnon E, Duclos S, Rondeau C, Chevet E, Cameron PH, Steele-Mortimer O, et al. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 2002; 110:119 - 31; http://dx.doi.org/10.1016/S0092-8674(02)00797-3; PMID: 12151002
   PubMed Web of Science ®Google Scholar
• Samuel CE. Antiviral actions of interferons. Clin Microbiol Rev 2001; 14:778 - 809; http://dx.doi.org/10.1128/CMR.14.4.778-809.2001; PMID: 11585785
   PubMed Web of Science ®Google Scholar
• Wu CY, Yang HY, Monie A, Ma B, Tsai HH, Wu TC, et al. Intraperitoneal administration of poly(I:C) with polyethylenimine leads to significant antitumor immunity against murine ovarian tumors. Cancer Immunol Immunother 2011; 60:1085 - 96; http://dx.doi.org/10.1007/s00262-011-1013-7; PMID: 21526359
   PubMed Web of Science ®Google Scholar
• Longhi MP, Trumpfheller C, Idoyaga J, Caskey M, Matos I, Kluger C, et al. Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant. J Exp Med 2009; 206:1589 - 602; http://dx.doi.org/10.1084/jem.20090247; PMID: 19564349
   PubMed Web of Science ®Google Scholar
• Kitano S, Kageyama S, Nagata Y, Miyahara Y, Hiasa A, Naota H, et al. HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan. Clin Cancer Res 2006; 12:7397 - 405; http://dx.doi.org/10.1158/1078-0432.CCR-06-1546; PMID: 17189412
   PubMed Web of Science ®Google Scholar
• Kushwah R, Hu J. Complexity of dendritic cell subsets and their function in the host immune system. Immunology 2011; 133:409 - 19; http://dx.doi.org/10.1111/j.1365-2567.2011.03457.x; PMID: 21627652
   PubMed Web of Science ®Google Scholar
• Asano K, Nabeyama A, Miyake Y, Qiu CH, Kurita A, Tomura M, et al. CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. Immunity 2011; 34:85 - 95; http://dx.doi.org/10.1016/j.immuni.2010.12.011; PMID: 21194983
   PubMed Web of Science ®Google Scholar
• Galea-Lauri J, Wells JW, Darling D, Harrison P, Farzaneh F. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination. Cancer Immunol Immunother 2004; 53:963 - 77; http://dx.doi.org/10.1007/s00262-004-0542-8; PMID: 15146294
   PubMed Web of Science ®Google Scholar
• Durand V, Wong SY, Tough DF, Le Bon A. Shaping of adaptive immune responses to soluble proteins by TLR agonists: a role for IFN-α/β. Immunol Cell Biol 2004; 82:596 - 602; http://dx.doi.org/10.1111/j.0818-9641.2004.01285.x; PMID: 15550117
   PubMed Web of Science ®Google Scholar
• Yamazaki S, Okada K, Maruyama A, Matsumoto M, Yagita H, Seya T. TLR2-dependent induction of IL-10 and Foxp3+ CD25+ CD4+ regulatory T cells prevents effective anti-tumor immunity induced by Pam2 lipopeptides in vivo. PLoS One 2011; 6:e18833; http://dx.doi.org/10.1371/journal.pone.0018833; PMID: 21533081
   PubMed Web of Science ®Google Scholar